Sodium hyaluronate 0.3% Serum

Polypharma has developed a Sodium hyaluronate 0.3% serum. Sodium hyaluronate, as hyaluronic acid, is a natural component of the skin and is used to smooth and tighten the skin, as well as to moisturise it.

Polypharma’s 30th anniversary

Next April Polypharma will have its 30th anniversary.

Much has been achieved during this period: development of a comprehensive  portfolio of human medicines, expansion of the generic portfolio to include veterinary medicine, support for the construction of local production facilities.

If you are interested in learning more about our corporate history, please consult our Milestones.


The most important objective since the company was founded remains:

To encourage local production in order to reduce drug imports in the MENA, East and West Africa regions and to combat counterfeiting

Why Polypharma cannot recommend its partners to package purchased bulk medicines

Many new customers find it interesting to pack already manufactured goods as a first step before producing their own medicines. Here are the reasons why Polypharma is against it:

  • From a pharmaceutical point of view, production and packaging in a GMP-compliant production line is the highest priority for the quality of the pharmaceuticals
  • Only with self-produced goods can you be 100% sure of the quality of the finished product
  • If the manufacturing process and subsequent packaging is interrupted, GMP-compliant goods cannot be guaranteed.
  • If finished pharmaceuticals are not packaged immediately after production, there is always the risk that they will be affected by fluctuations in humidity and temperature.
  • Bulk pharmaceuticals can be damaged during transport, resulting in a high level of loss of goods.
  • If you want to register bulk goods under your own name, you need a complete dossier, as well as all documentation of the active ingredient for registration with the local authority. It is questionable whether all necessary documentation can be obtained from the bulk producer.

Therefore, we recommend directly to produce your own production. If you would like further advice on this, please feel free to contact us.

Diclofenac diethylamine 1% gel

Polypharma has completed the preparation of a technical dossier for a gel based on 1% diethylamine diclofenac. Diclofenac diethylamine has an analgesic, anti-inflammatory and refreshing effect. It can be used to treat sports injuries, sunburn and arthritis.

Calcipotriol ointment developed

With this ointment Polypharma is also expanding its portfolio of dermatology products. A product extremely effective for the external treatment of psoriasis. This D3 derivative disrupts the growth and proliferation of keratinocytes and improves the disturbed cell separation.



Technologies & Sciences GmbH

Grosse Reichenstrasse 27
20457 Hamburg
+49 (0)40 37 480 3-0